FDA recall record

Fyremadel (ganirelix acetate) injection, 250 mcg/0.5 mL, One Single Dose Sterile Prefilled recall — FDA D-0569-2023

Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.

Class IIclassification
D-0569-2023official record ID
May 3, 2023report date

Recall record at a glance

Official recordD-0569-2023
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmSun Pharmaceutical Industries Ltd.
Report dateMay 3, 2023
Recall initiation dateApr 19, 2023
Quantity24194 Prefilled Syringes
LocationHalol, N/A, India

Official product description

Fyremadel (ganirelix acetate) injection, 250 mcg/0.5 mL, One Single Dose Sterile Prefilled Syringe 0.5 mL, For Subcutaneous Use, Rx Only, Sterile, Distributor: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054, USA, NDC 55566-1010-1

Why the product was recalled

Presence of Particulate Matter: A piece of glass was found in a prefilled syringe.

Distribution information

Nationwide in the USA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: N/A. Initial notification: N/A.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.